Proximal Humerus Fracture Dislocation Direction and Avascular Necrosis (PHF-D)

September 11, 2023 updated by: Fraser Orthopaedic Research Society

Association Between the Direction of Proximal Humerus Fracture Dislocation and Risk of Avascular Necrosis Following Open Reduction Internal Fixation - An Observational, Cohort Study

The purpose of the study is to see if there is a connection between a proximal humerus fracture dislocation direction and the likelihood of developing avascular necrosis. Utilizing a retrospective cohort from the last ten years we hope to bring consenting patients back for a single visit to have x-rays and complete patient reported outcome measures to assess for evidence of avascular necrosis.

Study Overview

Detailed Description

The incidence of proximal humerus fractures continues to increase and is among one of the more common fractures seen in the adult population. Proximal humerus fracture dislocations, however, are less common. Despite the decreased prevalence, fracture dislocations have unique challenges with respect to obtaining an anatomical reduction and more frequently involve an open surgical reduction. In addition, depending on other fracture characteristics, there are various treatment options for the fracture itself. While fracture dislocations ultimately lead to increased AVN and revision surgery, further discussion surrounding the direction of dislocation and how it may influence overall outcomes has not been addressed in the previous literature. The study design utilizes a retrospective cohort from the last ten years, by asking patients who have had a previously surgically treated proximal humerus fracture dislocations to come back to the surgeon's private clinic to complete a single visit assessment. During this assessment the consenting participant will receive x-rays and complete patient reported outcome measures. In conjunction, these will be utilized to assess overall function and the existence of avascular necrosis.

Study Type

Observational

Enrollment (Actual)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • New Westminster, British Columbia, Canada, V3L 3W7
        • Royal Columbian Hospital/Fraser Health Authority

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Skeletally mature patients who were surgically treated for their proximal humerus fracture dislocation between 2011 and 2021.

Description

Inclusion Criteria:

  • Patients 18 years of age or older
  • Patients who underwent operative fixation of proximal humerus fracture dislocation at Royal Columbian Hospital between January 2011 and July 2021
  • Willing and able to consent and complete patient reported outcome measures
  • Willing and able to follow the protocol and attend a follow-up visit
  • Able to read and understand English or have an interpreter available

Exclusion Criteria:

  • Skeletally immature patients
  • Patient with pathological fractures
  • Patients who have had previous operative fixation of proximal humerus
  • Patients treated non-operatively
  • patients presenting outside of the study duration window
  • Patients treated by a non-participating surgeon
  • Deceased patients
  • Patients unable to complete patient reported outcome measures
  • Patients declining to come back to the clinic for updated x-rays
  • Dementia
  • Incarceration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Proximal Humerus Fracture Anterior Dislocation
The study doesn't provide any intervention. This group is defined as having a dislocation that is anterior to the glenoid.
Proximal Humerus Fracture Posterior Dislocation
The study doesn't provide any intervention. This group is defined as having a dislocation that is posterior to the glenoid.
Consenting participants will be asked to come into the clinic for a single visit, during this visit they will be asked to complete an x-ray to check for evidence of avascular necrosis.
Proximal Humerus Fracture Varus Dislocation
The study doesn't provide any intervention. This group is defined as having a dislocation that is in varus compared to the glenoid.
Consenting participants will be asked to come into the clinic for a single visit, during this visit they will be asked to complete an x-ray to check for evidence of avascular necrosis.
Proximal Humerus Fracture Valgus Dislocation
The study doesn't provide any intervention. This group is defined as having a dislocation that is in valgus compared to the gelnoid.
Consenting participants will be asked to come into the clinic for a single visit, during this visit they will be asked to complete an x-ray to check for evidence of avascular necrosis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rates of Avascular Necrosis
Time Frame: At least 2 years post fracture fixation
The presence and advancement of avascular necrosis (as classified by the Cruess Classification System) and as assessed on radiographs.
At least 2 years post fracture fixation
Direction of the Humeral Fracture Dislocation
Time Frame: At least 2 years post fracture fixation
As characterized by the direction of the humeral head in relation to the glenoid, based on AP, Lateral, or Axillary x-ray views.
At least 2 years post fracture fixation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DASH (functional outcome)
Time Frame: At least 2 years post fracture fixation
Asking participants to complete the Disabilities of the Arm, Shoulder, and Hand outcome measure as a way of assessing function.
At least 2 years post fracture fixation
Constant Score (functional outcome)
Time Frame: At least 2 years post fracture fixation
Asking participants to complete the Constant Score patient reported outcome measure as a way of assessing participant function.
At least 2 years post fracture fixation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Farhad Moola, MD, FHA Orthopaedic Surgeon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2023

Primary Completion (Actual)

July 31, 2023

Study Completion (Actual)

August 31, 2023

Study Registration Dates

First Submitted

January 27, 2023

First Submitted That Met QC Criteria

February 9, 2023

First Posted (Actual)

February 21, 2023

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 11, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is currently no plan to share individual participant data with other researchers, results will of course be shared. However, the hope is that the study might indicate a need for a high powered prospective clinical trial to be completed.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Avascular Necrosis

Clinical Trials on X-Ray

Subscribe